Vivus' Offering Raises $21M For Sexual Dysfunction Trials March 11, 2005 By Jennifer Boggs Vivus Inc. is raising $21.25 million in a public offering to fund clinical trials for four product candidates in sexual dysfunction. (BioWorld Today)Read More
RSS